+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Ablation Devices Market 2019-2025

  • ID: 4896917
  • Report
  • March 2019
  • Region: Global
  • Orion Market Research Private Limited

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • AtriCure, Inc.
  • CONMED Corp.
  • Hologic, Inc.
  • Misonix, Inc.
  • Stryker Corp.
Ablation Devices Market Size, Share & Trends Analysis Report, By Product Type (Radiofrequency, Microwave, Cryoablation, Ultrasound, and Others), By Application (Cancer, CVD, Ophthalmology, Gynecology, Orthopedics, Urology, and Others), By Treatment (Surgical Ablation, Percutaneous Ablation, and Laparoscopic Ablation), and Forecast, 2019-2025.

The global ablation devices are estimated to grow significantly during the forecast period. Rising demand for minimally invasive surgical instruments and significant prevalence of chronic diseases are primarily boosting the market growth. With the increasing demand for minimally invasive surgical procedures, a significant number of players are working on the development of minimally invasive surgical devices that will allow physicians to deliver more safe and reliable treatment to the patients. Ablation devices are used to perform minimally invasive surgeries for the treatment of several diseases, including cancer, CVD, gynecology, and urology.

There are several advances in atrial fibrillation ablation devices has been reported over the years. For instance, in June 2019, Abbott declared the introduction of its HD grid mapping catheter, which is sensor-enabled, in India. It has gained the US FDA clearance in May 2018. Owing to a new design, the catheter enables physicians to monitor things differently and capture and evaluate data in a novel way for highly comprehensive heart mapping. This, in turn, facilitates to effectively differentiate healthy tissue from unhealthy tissue. To deliver effective outcomes for patients, physicians need to evaluate which heart areas contain those pathways. Therefore, mapping catheters enables to offer insights by providing an inside view of the heart. As a result, it allows physicians to offer more precise ablation therapy and leads to the growth of the ablation procedures.

Geographically, North America has witnessed significant share in the market in 2018 owing to the significant presence of major players, including Johnson & Johnson Services, Inc. and Abbott Laboratories, Inc. in the region. Asia-Pacific is estimated to grow significantly during the forecast period owing to the emerging concept of multi-specialty hospitals in the region. In addition, the rising prevalence of lifestyle-oriented diseases is expected to boost market growth in the region. Some crucial players in the market include Medtronic plc, Abbott Laboratories, Inc., Boston Scientific Corp., AngioDynamics, Inc., and Johnson & Johnson Services, Inc. Mergers and acquisitions, product launches and partnerships and collaborations are considered as crucial strategies adopted by the market players to expand market share and gain a competitive advantage over their competitors.

Research Methodology

The market study of the global ablation devices market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.

Secondary sources include:
  • Financial reports of companies involved in the market.
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalogue.

The report is intended for providers of medical devices, government agencies, and medical research institutes, for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:
  • Global Ablation Devices Market Research and Analysis, By Product Type
  • Global Ablation Devices Market Research and Analysis, By Application
  • Global Ablation Devices Market Research and Analysis, By Treatment

The Report covers:
  • Comprehensive research methodologies of the global ablation devices market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global ablation devices market.
  • Insights about market determinants which are stimulating the global ablation devices market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • AtriCure, Inc.
  • CONMED Corp.
  • Hologic, Inc.
  • Misonix, Inc.
  • Stryker Corp.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations

3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Medtronic plc
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Boston Scientific Corp.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. AngioDynamics, Inc.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Abbott Laboratories, Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Johnson & Johnson Services, Inc.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments

4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities

5. Market Segmentation
5.1. Global Ablation Devices Market by Product Type
5.1.1. Radiofrequency
5.1.2. Microwave
5.1.3. Cryoablation
5.1.4. Ultrasound
5.1.5. Others (Laser and Electrical)
5.2. Global Ablation Devices Market by Application
5.2.1. Cancer
5.2.2. CVD
5.2.3. Ophthalmology
5.2.4. Gynecology
5.2.5. Orthopedics
5.2.6. Urology
5.2.7. Others (Aesthetics and Pain Management)

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World

7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. Alcon Laboratories, Inc.
7.3. AngioDynamics, Inc.
7.4. AtriCure, Inc.
7.5. Boston Scientific Corp.
7.6. BVM Medical Ltd.
7.7. C. R. Bard, Inc. (a part of Becton, Dickinson & Co.)
7.8. CONMED Corp.
7.9. EDAP TMS SA
7.10. HealthTronics, Inc.
7.11. Hologic, Inc.
7.12. Integra LifeSciences Holdings Corp.
7.13. Japan Lifeline Co., Ltd.
7.14. Johnson & Johnson Services, Inc.
7.15. Medtronic plc
7.16. Merit Medical Systems, Inc.
7.17. Misonix, Inc.
7.18. Olympus Corp.
7.19. Smith & Nephew plc
7.20. Stryker Corp.
7.21. Teleflex, Inc.
7.22. Terumo Corp.
7.23. Varian Medical Systems, Inc."
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • Alcon Laboratories, Inc.
  • AngioDynamics, Inc.
  • AtriCure, Inc.
  • Boston Scientific Corp.
  • BVM Medical Ltd.
  • C. R. Bard, Inc. (a part of Becton, Dickinson & Co.)
  • CONMED Corp.
  • EDAP TMS SA
  • HealthTronics, Inc.
  • Hologic, Inc.
  • Integra LifeSciences Holdings Corp.
  • Japan Lifeline Co., Ltd.
  • Johnson & Johnson Services, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Misonix, Inc.
  • Olympus Corp.
  • Smith & Nephew plc
  • Stryker Corp.
  • Teleflex, Inc.
  • Terumo Corp.
  • Varian Medical Systems, Inc."
Note: Product cover images may vary from those shown